The standard of care in locally advanced rectal cancer is neoadjuvant chemoradiation
(nCRT) followed by radical surgery. Response to nCRT varies among patients and …

Aim Approximately 20% of patients treated with neoadjuvant chemoradiotherapy (nCRT) for
locally advanced rectal cancer achieve a pathological complete response (p CR) while the …

We asked what preoperative radiotherapy/chemoradiotherapy (PRT/PCRT) has brought to
patients in terms of perioperative and long‐term outcomes over the past decades. A …

Background Some patients with rectal cancer who receive neoadjuvant chemoradiotherapy
(nCRT) achieve a pathologic complete response (pCR) and may be eligible for less radical …

Abstract Purpose of Review Pathological complete response is seen in approximately one
fifth of rectal cancer patients following neoadjuvant chemoradiation. Since these patients …

BACKGROUND: Preoperative chemoradiation therapy in patients with rectal cancer results
in pathologic complete response in approximately 10% to 30% of patients. Accurate …

Background: Patients with rectal cancer who achieve pathologic complete response (pCR)
after neoadjuvant chemoradiotherapy (nCRT) may have a better prognosis and may be …

Aims: There is a growing body of evidence showing the functional relationship between
inflammation index like netrophil-lymphocyte ratio.(NLR) and colorectal cancer.(CRC) in …

Objective Approximately 10–40% of rectal patients have a complete response (CR) to
neoadjuvant chemoradiation (CRT), and these patients have improved survival. Thus, non …

Introduction Preoperative chemoradiotherapy (CRT), followed by total mesorectal excision,
has become the standard of care for patients with clinical stages II and III rectal cancer …